topic

181 Associations between multimodal immune biomarkers and clinical outcomes in a real-world non-small cell lung cancer cohort
Michelle M Stein, Mario Rosasco, Denise Lau, Yinjie Gao, Rotem Ben-Shachar, Justin Guinney, Halla Nimeiri, Nisha Mohindra

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A205; DOI: 10.1136/jitc-2023-SITC2023.0181
182 Peripheral immunological features as predictors of breast cancer chemoimmunotherapy response
Xiaopeng Sun, Brandie C Taylor, Margaret Axelrod, Lamorna Swigart, Laura van ‘t Veer, Gillian Hirst, Justin M Balko

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A206; DOI: 10.1136/jitc-2023-SITC2023.0182
183 Comprehensive genomic and immune profiling (CGIP) reveals a distinct genomic and immune gene expression profile for younger patients with non-small cell lung cancer (NSCLC)
Zachary D Wallen, Heidi Ko, Mary K Nesline, Stephanie B Hastings, Kyle C Strickland, Rebecca A Previs, Shengle Zhang, Sarabjot Pabla, Jeffrey M Conroy, Jennifer B Jackson, Kamal S Saini, Taylor J Jensen, Brian Caveney, Pratheesh Sathyan, Prasanth Reddy, Eric A Severson, Shakti Ramkissoon

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A207; DOI: 10.1136/jitc-2023-SITC2023.0183
184 Distinct immunotherapy immune response phenotypes in non-small cell lung cancer present with unique genomic alteration profiles
Zachary D Wallen, RJ Seager, Sarabjot Pabla, Mary K Nesline, Erik Van Roey, Shuang Gao, Maria-Fernanda Senosain, Stephanie B Hastings, Kyle C Strickland, Rebecca A Previs, Shengle Zhang, Jeffrey M Conroy, Taylor J Jensen, Marcia Eisenberg, Brian Caveney, Prasanth Reddy, Eric A Severson, Shakti Ramkissoon

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A208; DOI: 10.1136/jitc-2023-SITC2023.0184
185 Global and local copy number aberration signatures as prognostic and immunotherapeutic predictors
Xuefeng Wang, Tingyi Li, Timothy I Shaw, Sijie Yao, Islam Eljilany, Martin D McCarter, Abdul Rafeh Naqash, Margaret E Gatti-Mays, Aakrosh Ratan, John Carpten, Howard Colman, Igor Puzanov, Susanne M Arnold, Michelle Churchman, Patrick Hwu, William S Dalton, George J Weiner, Ahmad A Tarhini

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A209; DOI: 10.1136/jitc-2023-SITC2023.0185
186 Novel analysis strategy of T-cell receptor NGS data to develop patient-specific clonotype panels and detect minimal residual disease (MRD) in T-cell acute lymphoblastic leukemia (T-ALL)
Nicholas A Young

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A210; DOI: 10.1136/jitc-2023-SITC2023.0186
187 Immune checkpoint inhibitor (CPI) efficacy in gastrointestinal tumors with microsatellite-stable with high tumor mutational burden (MSS-TMB-H) compared to microsatellite instability-high (MSI-H)
James Yu, Robin Park, Ruoyu Miao, Iman Imanirad, Jose Laborde, Todd Knepper, Christine Walko, Richard D Kim

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A211-A213; DOI: 10.1136/jitc-2023-SITC2023.0187
188 Molecular profiling of patients with colorectal cancer and their clinical implications
Qinqin Zha, Frank Scarpa, Anna Juncker-Jensen, Dennis Merkle

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A214; DOI: 10.1136/jitc-2023-SITC2023.0188
189 Systematic evaluation of transcriptomic molecular features in advanced renal clear cell carcinoma treated with immunotherapy
Chi Zhang, Hu Ma, Benjamin Frey, Jian-Guo Zhou, Udo Gaipl

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A215; DOI: 10.1136/jitc-2023-SITC2023.0189
190 Utilizing a peptide-based approach to target and evaluate novel biomarker Neu5Gc Sialyl Lewis A in cancer
Shelby Knoche, Indu Venugopal, Michael J McGuire, Kathlynn C Brown

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A216; DOI: 10.1136/jitc-2023-SITC2023.0190

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages